International law firm McDermott Will & Schulte represented WindRose Health Investors (WindRose), a New York-based healthcare private equity firm, in an investment in Avalon Healthcare Solutions (Avalon), a platform that integrates laboratory science and data to power real-time, lab-driven insights on behalf of health plan clients.

WindRose’s experience scaling tech-enabled payer services solutions will enable Avalon to accelerate its growth trajectory, invest in novel product offerings, and further develop its next-generation technology platform. Francisco Partners, a leading global investment firm that specializes in partnering with technology businesses, also made an additional investment at this time.

The McDermott team was led by Krist Werling and Jarrett Szczesny with invaluable assistance from Mike Nowicki, Jake Schindler, Erin Kelly, Joseph Anderson, Grayson Dimick, Noah Feldman Greene, Nathan Gray, Deepak Tamasker, Smith Alpert, Alex Ruiz, Stephania Sanon, Ellie Atkins, Olivia Palmer, James Cannatti, Patrick Ryan, Jennifer Hill, Larissa Mussi, Greg Heltzer, Jennifer Mikulina, Wendy Phinny, Michael Ryan, Megan Ingram, Paul Gadiock, Sam Siegfried, and Kate Williams.

Read WindRose’s press release.

McDermott advised WindRose on its sale of BPD Healthcare in October of last year.

About McDermott Will & Schulte’s Private Equity Group

With more than 150 private equity-focused lawyers working across offices globally, McDermott Will & Schulte’s Private Equity Group is poised to help clients stay ahead of the curve on all types of PE transactions, including fund formation, mergers and acquisitions, minority and majority investments, and leveraged buyouts. Legal 500 notes our team’s “ability to understand the business and specific needs of the client.” We anticipate the unknown and deliver actionable solutions, aligning our strategy and advice with clients’ objectives and guiding them through each step of the private equity life cycle. At every stage, we manage and assess risks and opportunities while looking for the most efficient way to get the deal done. Our team of leading private equity practitioners offers deep industry experience in the healthcare, life sciences, food and beverage, energy, real estate, insurance, and technology sectors – along with the cross-border and cross-practice capabilities critical to facilitating business success. When you work with us, Always Better isn’t just our goal – it’s your advantage.

About McDermott Will & Schulte’s Health & Life Sciences Group

McDermott Will & Schulte’s internationally recognized healthcare and life sciences practice addresses the critical legal and business needs of leading industry players. You can turn to us to drive innovative deals and navigate high-stakes disputes, enforcement risks, and complex regulatory issues. Our global team leverages deep market intelligence and decades of experience representing clients across all subsectors, including health systems and other providers, payors, private equity and other investors, major healthcare and life sciences companies, health technology developers, and new market entrants. Serving as a convener, we foster meaningful partnerships and thought leadership through our premier conferences. We stand as the only healthcare practice to receive top rankings from Best Law Firms, Chambers, Legal 500, and Law360 (which has named us “Practice Group of the Year for Healthcare” multiple times), while also ranking among the leading life sciences law firms. When you work with us, Always Better isn’t just our goal – it’s your advantage.